However, later studies found that three previously reported pathogenic variants are benign polymorphisms in the Australian population, indicating that BARD1 is not accurate enough to represent the high-penetrance susceptibility gene of breast cancer (Gorringe et al., 2008). The gene discussed is BARD1; the disease is breast carcinoma.